Subject of the research is the treatment of liver fibrosis by developing novel cell-specific nanotherapeutics for the treatment of liver diseases

Research output: Contribution to journalArticlePopular

2 Downloads (Pure)

Abstract

Research Highlighted (Hoe Gaat Het Eigenlijk met Ruchi Bansal) in the NVH liver magazine (LEVER) of September 2015 (pages 7 & 9).
Original languageEnglish
Pages (from-to)7-9
JournalLever
Volume39
Issue number3
Publication statusPublished - 2015

Fingerprint

Liver Cirrhosis
Liver Diseases
Liver
Research

Cite this

@article{b02a0c48becc484680608326b4d790d8,
title = "Subject of the research is the treatment of liver fibrosis by developing novel cell-specific nanotherapeutics for the treatment of liver diseases",
abstract = "Research Highlighted (Hoe Gaat Het Eigenlijk met Ruchi Bansal) in the NVH liver magazine (LEVER) of September 2015 (pages 7 & 9).",
author = "Ruchi Bansal",
year = "2015",
language = "English",
volume = "39",
pages = "7--9",
journal = "Lever",
issn = "1574-7867",
publisher = "Nederlandse Vereniging voor Hepatologie",
number = "3",

}

TY - JOUR

T1 - Subject of the research is the treatment of liver fibrosis by developing novel cell-specific nanotherapeutics for the treatment of liver diseases

AU - Bansal, Ruchi

PY - 2015

Y1 - 2015

N2 - Research Highlighted (Hoe Gaat Het Eigenlijk met Ruchi Bansal) in the NVH liver magazine (LEVER) of September 2015 (pages 7 & 9).

AB - Research Highlighted (Hoe Gaat Het Eigenlijk met Ruchi Bansal) in the NVH liver magazine (LEVER) of September 2015 (pages 7 & 9).

M3 - Article

VL - 39

SP - 7

EP - 9

JO - Lever

JF - Lever

SN - 1574-7867

IS - 3

ER -